• Nenhum resultado encontrado

The use of a stably expressed FRET biosensor for determining the potency of cancer drugs.

N/A
N/A
Protected

Academic year: 2017

Share "The use of a stably expressed FRET biosensor for determining the potency of cancer drugs."

Copied!
10
0
0

Texto

Loading

Imagem

Table 1. MB231_CFP-YFP dose response EC 50 values for different cancer products.
Figure 4. Cell-based FRET biosensor provides a quantifiable response to treatments of death receptor targeted cancer therapies.

Referências

Documentos relacionados

We compared the proliferation of the human breast cancer cell line MDA-MB-231 and of the non-cancer human mammary epithelial cell line MCF-10A in different experimental

Indígena criada na zona urbana, não esqueceu suas raízes e decidiu retornar a Recife. Eliane tomou consciência da urgência do momento político ao retornar ao seu lugar de

This work describes the development of a label free immunosensor based on screen-printed AuNPs/carbon and the characterization of its analytical response for staphylococcal

42 The presentation concluded that ADT is associated with an increased risk of CV events; however, the GnRH antagonist degarelix may be a promising drug, ofering increased

The effect caused by the TLC purified yellow pigment on the growth and proliferation of Human cervical cancer cell line (HeLa) and Human liver cancer cell line

The increased levels of caspase-3 activation suggest that silver nanoparticles induced apoptosis in MCF 7 breast cancer cells in a caspase-3-dependent manner..

Expression of the A88V and G11R mutants resulted in elevated levels of the cleaved forms of caspase-3, caspase-8, caspase-9, and PARP, which are all markers of apoptotic

Figure 2 – Concentration dependent caspase 3/7 activity in PC-3 cell line following exposure to zoledronic acid. PC-3 cell line was treated with increasing concentrations of